OACC Stock Chart & Stats
$10.64
>-$0.01(-0.10%)
At close: 4:00 PM EST
$10.64
>-$0.01(-0.10%)
Day’s Range― - ―
52-Week Range$10.30 - $10.75
Previous CloseN/A
Volume44.20K
Average Volume (3M)63.92K
Market Cap
$263.04M
Enterprise Value$260.54M
Total Cash (Recent Filing)$1.28M
Total Debt (Recent Filing)$11.82K
Price to Earnings (P/E)37.0
Beta0.05
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.29
Shares Outstanding19,783,010
10 Day Avg. Volume60,630
30 Day Avg. Volume63,922
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.04
Price to Sales (P/S)0.00
P/FCF Ratio-481.25
Enterprise Value/Market Cap0.99
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-215.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Oaktree Acquisition Corp. III Life Sciences Class A News
OACC FAQ
What was Oaktree Acquisition Corp. III Life Sciences Class A’s price range in the past 12 months?
Oaktree Acquisition Corp. III Life Sciences Class A lowest stock price was $10.30 and its highest was $10.75 in the past 12 months.
What is Oaktree Acquisition Corp. III Life Sciences Class A’s market cap?
Oaktree Acquisition Corp. III Life Sciences Class A’s market cap is $263.04M.
When is Oaktree Acquisition Corp. III Life Sciences Class A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Oaktree Acquisition Corp. III Life Sciences Class A’s earnings last quarter?
Currently, no data Available
Is Oaktree Acquisition Corp. III Life Sciences Class A overvalued?
According to Wall Street analysts Oaktree Acquisition Corp. III Life Sciences Class A’s price is currently Overvalued.
Does Oaktree Acquisition Corp. III Life Sciences Class A pay dividends?
Oaktree Acquisition Corp. III Life Sciences Class A does not currently pay dividends.
What is Oaktree Acquisition Corp. III Life Sciences Class A’s EPS estimate?
Oaktree Acquisition Corp. III Life Sciences Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oaktree Acquisition Corp. III Life Sciences Class A have?
Oaktree Acquisition Corp. III Life Sciences Class A has 19,783,010 shares outstanding.
What happened to Oaktree Acquisition Corp. III Life Sciences Class A’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oaktree Acquisition Corp. III Life Sciences Class A?
Currently, no hedge funds are holding shares in OACC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oaktree Acquisition Corp. III Life Sciences Class A Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
3.63%
Trailing 12-Months
Asset Growth
3.85%
Trailing 12-Months
Company Description
Oaktree Acquisition Corp. III Life Sciences Class A
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Technical Analysis
Ownership Overview
―
Insiders
3.46% Mutual Funds
61.38% Other Institutional Investors
34.80% Public Companies and
Individual Investors